Vimarsana
Biggest News Aggregation in the World

Import Authorisation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Import Authorisation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Import Authorisation Today - Breaking & Trending Today

IT import curbs LIVE: Government may require International certification for IT hardware imports - Vimarsana News

IT import curbs LIVE: Government may require International certification for IT hardware imports

IT imports curbs LIVE Updates: Office of the Prime Minister of Israel tweets,

Imports of laptops, servers for sale in market not exempt from licensing in new rules - Vimarsana News

Imports of laptops, servers for sale in market not exempt from licensing in new rules

The government issued a notification on Thursday stating that notified IT hardware items essential for Capital Goods are exempt from import licensing requirements.For instance, laptops/tablets accompanying machinery such as MRI machines, CNC ...

Import authorisation norms will not lead to laptop, tablet and PC price rise: MeitY secretary - Vimarsana News

Import authorisation norms will not lead to laptop, tablet and PC price rise: MeitY secretary

Officials of the Ministry of Electronics and Information Technology and Directorate General of Foreign Trade said import authorisation requests will not be rejected for now, and the data will be studied before further decisions are taken

In review: the life sciences regulatory regime in Malta - Vimarsana News

In review: the life sciences regulatory regime in Malta

This article reviews the essential regulatory considerations surrounding medicines and medical devices in Malta, including clinical trials and marketing authorisations.

In review: the life sciences regulatory regime in United Kingdom - Vimarsana News

In review: the life sciences regulatory regime in United Kingdom

This article reviews the essential regulatory considerations surrounding medicines and medical devices in United Kingdom, including clinical trials and marketing authorisations.